Andere Sprachen Iqvia Holdings Inc.

Aktien

A2JSPM

US46266C1053

IQV

Biotechnologie

Markt geschlossen - Nyse Andere Börsenplätze 22:00:02 15.01.2026			% 5 Tage	Veränd. 1. Jan.
241,28 ^USD	-0,03 %		-1,23 %	+7,04 %

15.01.	Pharmasektor setzt verstärkt auf KI in der Hoffnung, Kosten und Entwicklungszeiten drastisch zu senken	RE
15.01.	Zydus Lifesciences Limited erhält endgültige Zulassung der USFDA für Eltrombopag-Tabletten in den Dosierungen 12,5 mg, 25 mg, 50 mg und 75 mg	CI

Andere Sprachen

15.01.	Pharma sector doubles down on AI amid hopes of slashing costs, timelines
15.01.	Zydus Lifesciences Limited Receives Final Approval from USFDA for Eltrombopag Tablets, 12.5 mg, 25 mg, 50 mg, and 75 mg
12.01.	Alembic Pharmaceuticals Limited Receives USFDA Tentative Approval for Bosutinib Tablets, 400 Mg
08.01.	Syneos Health, Inc. Appoints Simon Bartle as Chief Human Resources Officer, Effective January 8, 2026
30.12.	M&S launches new food range for customers on weight-loss jabs
26.12.	Formosa Pharmaceuticals, Inc. Receives Screening Acceptance Letter from SAHPRA for the Registration of App13007
22.12.	Granules India Arm Gets US FDA's Tentative Nod for Generic Amphetamine Extended-Release Tablets
18.12.	Alembic Pharmaceuticals Limited Announces USFDA Final Approval for Travoprost Ophthalmic Solution USP, 0.004% (Ionic Buffered Solution
18.12.	Bavarian Nordic as Appoints Anne Louise Eberhard as New Chair of the Board of Directors
11.12.	Glenmark Pharmaceuticals to Launch Leucovorin Calcium for Injection
10.12.	Scienture and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli, the First FDA-Approved Ready-To-Use Oral Suspension of Losartan Potassium
10.12.	IFyber Expands Analytical Capabilities with Launch of Advanced LC-MS Services
09.12.	IQVIA Holdings Inc. Enter into an Amendment to Its Fifth Amended and Restated Credit Agreement
08.12.	Halozyme Therapeutics, Inc. Announces Election of Jim Lang to Board of Directors, Effective December 4, 2025
02.12.	Amneal Pharmaceuticals, Inc. Receives U.S. Fda Approval for Albuterol Sulfate Inhalation Aerosol
02.12.	Iqvia announces strategic collaboration with AWS, naming AWS as preferred agentic cloud provider to power next-generation AI platform
02.12.	IQVIA Names AWS as Preferred Agentic Cloud Partner for New AI Platform
02.12.	IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform
01.12.	Amneal Announces U.S. Fda Approval of Cyclosporine Ophthalmic Emulsion 0.05%
01.12.	Lupin Gets US FDA Nod for Biosimilar Armlupeg
26.11.	Shandong Boan Biotechnology Co., Ltd. Receives Marketing Approval for its Aflibercept Intravitreous Injection, Boyoujing
14.11.	Zydus Lifesciences Limited Receives Final Approval from Usfda for Leuprolide Acetate Injection, 14 Mg/2.8Ml (1 Mg/0.2 Ml) Multiple-Dose Vial
12.11.	Atea Pharmaceuticals, Inc. Announces Research Findings, Including Evidence of A Unique Dual Mechanism of Action for Bemnifosbuvir Against Hepatitis C Virus and the Expansion of the Company's Antiviral Pipeline with A New Hepatitis E Virus Program
06.11.	Dr. William G. Kaelin Jr. joins IQVIA board of directors
05.11.	Dr. William G. Kaelin Jr. joins IQVIA Board of Directors

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen MarketScreener Artikel MarketScreener Analysen Trading-Ideen

Andere Sprachen Iqvia Holdings Inc.

Aktien

A2JSPM

US46266C1053

IQV

Biotechnologie

Andere Sprachen

Filter